Sanofi-Aventis to strengthen R&D in Korea

Published: 2009-06-10 06:58:00

Updated: 2009-06-10 06:58:00

Sanofi-Aventis, a France-based pharmaceutical company, plans to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in major fields of medicine development.

Sanofi-Aventis's Senior Vice President Research and Development Marc Cluzel and some six officials are scheduled to visit Korea between June 15 and 17 to proceed ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.